Dendreon Corporation
(Other OTC/NBB : DNDN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
MDTMedtronic PLC
ABTAbbott Laboratories
TMOThermo Fisher Scientific Inc.
ISRGIntuitive Surgical, Inc.
BDXBecton, Dickinson and Company
ALGNAlign Technology, Inc.
SYKStryker Corporation
BAXBaxter International Inc.
BSXBoston Scientific Corporation
EWEdwards Lifesciences Corporation
ZBHZimmer Biomet Holdings, Inc.
COOCooper Companies, Inc.
XRAYDENTSPLY International Inc.
IDXXIDEXX Laboratories, Inc.

Company Profile

Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA.